{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:51:35Z","timestamp":1791150695940,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T00:00:00Z","timestamp":1253059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00262-009-0763-y","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T12:30:53Z","timestamp":1253017853000},"page":"441-452","source":"Crossref","is-referenced-by-count":39,"title":["Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs"],"prefix":"10.1007","volume":"59","author":[{"given":"Scott","family":"Hafeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Elmslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Dow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,16]]},"reference":[{"key":"763_CR1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000372-200002000-00009","volume":"22","author":"VK Affolter","year":"2000","unstructured":"Affolter VK, Moore PF (2000) Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells. Am J Dermatopathol 22:40\u201348","journal-title":"Am J Dermatopathol"},{"key":"763_CR2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1354\/vp.39-1-74","volume":"39","author":"VK Affolter","year":"2002","unstructured":"Affolter VK, Moore PF (2002) Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Vet Pathol 39:74\u201383","journal-title":"Vet Pathol"},{"key":"763_CR3","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V96.8.2834","volume":"96","author":"F Alves-Rosa","year":"2000","unstructured":"Alves-Rosa F, Stanganelli C, Cabrera J, van Rooijen N, Palermo MS, Isturiz MA (2000) Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model. Blood 96:2834\u20132840","journal-title":"Blood"},{"key":"763_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.vetimm.2008.02.013","volume":"123","author":"RC Bird","year":"2008","unstructured":"Bird RC, Deinnocentes P, Lenz S, Thacker EE, Curiel DT, Smith BF (2008) An allogeneic hybrid-cell fusion vaccine against canine mammary cancer. Vet Immunol Immunopathol 123:289\u2013304","journal-title":"Vet Immunol Immunopathol"},{"key":"763_CR5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8588(05)70523-2","volume":"12","author":"P Bucsky","year":"1998","unstructured":"Bucsky P, Egeler RM (1998) Malignant histiocytic disorders in children. Clinical and therapeutic approaches with a nosologic discussion. Hematol Oncol Clin North Am 12:465\u2013471","journal-title":"Hematol Oncol Clin North Am"},{"key":"763_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jbmr.5650020209","volume":"2","author":"MG Cecchini","year":"1987","unstructured":"Cecchini MG, Felix R, Fleisch H, Cooper PH (1987) Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages. J Bone Miner Res 2:135\u2013142","journal-title":"J Bone Miner Res"},{"key":"763_CR7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/0929867033368529","volume":"10","author":"P Clezardin","year":"2003","unstructured":"Clezardin P, Fournier P, Boissier S, Peyruchaud O (2003) In vitro and in vivo antitumor effects of bisphosphonates. Curr Med Chem 10:173\u2013180","journal-title":"Curr Med Chem"},{"key":"763_CR8","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1172\/JCI510","volume":"101","author":"SW Dow","year":"1998","unstructured":"Dow SW, Elmslie RE, Willson AP, Roche L, Gorman C, Potter TA (1998) In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. J Clin Invest 101:2406\u20132414","journal-title":"J Clin Invest"},{"key":"763_CR9","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E","volume":"44","author":"JC Frith","year":"2001","unstructured":"Frith JC, Monkkonen J, Auriola S, Monkkonen H, Rogers MJ (2001) The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum 44:2201\u20132210","journal-title":"Arthritis Rheum"},{"key":"763_CR10","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1359\/jbmr.1997.12.9.1358","volume":"12","author":"JC Frith","year":"1997","unstructured":"Frith JC, Monkkonen J, Blackburn GM, Russell RG, Rogers MJ (1997) Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5\u2032-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 12:1358\u20131367","journal-title":"J Bone Miner Res"},{"key":"763_CR11","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/sj.jid.5700827","volume":"127","author":"S Gazzaniga","year":"2007","unstructured":"Gazzaniga S, Bravo AI, Guglielmotti A, van Rooijen N, Maschi F, Vecchi A, Mantovani A, Mordoh J, Wainstok R (2007) Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol 127:2031\u20132041","journal-title":"J Invest Dermatol"},{"key":"763_CR12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/cncr.11128","volume":"97","author":"JR Green","year":"2003","unstructured":"Green JR (2003) Antitumor effects of bisphosphonates. Cancer 97:840\u2013847","journal-title":"Cancer"},{"key":"763_CR13","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2278::AID-CNCR25>3.0.CO;2-U","volume":"85","author":"DM Howarth","year":"1999","unstructured":"Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ (1999) Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 85:2278\u20132290","journal-title":"Cancer"},{"key":"763_CR14","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","volume":"10","author":"DE Hughes","year":"1995","unstructured":"Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478\u20131487","journal-title":"J Bone Miner Res"},{"key":"763_CR15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/blood-2001-11-0061","volume":"101","author":"MB Jordan","year":"2003","unstructured":"Jordan MB, van Rooijen N, Izui S, Kappler J, Marrack P (2003) Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. Blood 101:594\u2013601","journal-title":"Blood"},{"key":"763_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0773.1991.tb01312.x","volume":"69","author":"L Lauren","year":"1991","unstructured":"Lauren L, Osterman T, Karhi T (1991) Pharmacokinetics of clodronate after single intravenous, intramuscular and subcutaneous injections in rats. Pharmacol Toxicol 69:365\u2013368","journal-title":"Pharmacol Toxicol"},{"key":"763_CR17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1124\/mol.61.5.1255","volume":"61","author":"PP Lehenkari","year":"2002","unstructured":"Lehenkari PP, Kellinsalmi M, Napankangas JP, Ylitalo KV, Monkkonen J, Rogers MJ, Azhayev A, Vaananen HK, Hassinen IE (2002) Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP\/ATP translocase by a nonhydrolyzable, adenine-containing metabolite. Mol Pharmacol 61:1255\u20131262","journal-title":"Mol Pharmacol"},{"key":"763_CR18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","volume":"18","author":"JH Lin","year":"1996","unstructured":"Lin JH (1996) Bisphosphonates: a review of their pharmacokinetic properties. Bone 18:75\u201385","journal-title":"Bone"},{"key":"763_CR19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0022-1759(83)90097-2","volume":"57","author":"JD Loike","year":"1983","unstructured":"Loike JD, Silverstein SC (1983) A fluorescence quenching technique using trypan blue to differentiate between attached and ingested glutaraldehyde-fixed red blood cells in phagocytosing murine macrophages. J Immunol Methods 57:373\u2013379","journal-title":"J Immunol Methods"},{"key":"763_CR20","volume-title":"Small animal clinical oncology","author":"EG MacEwen","year":"1996","unstructured":"MacEwen EG, Withrow SJ (1996) Small animal clinical oncology. Saunders Co, Philadelphia, PA"},{"key":"763_CR21","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.exphem.2006.05.014","volume":"34","author":"M Mathes","year":"2006","unstructured":"Mathes M, Jordan M, Dow S (2006) Evaluation of liposomal clodronate in experimental spontaneous autoimmune hemolytic anemia in dogs. Exp Hematol 34:1393\u20131402","journal-title":"Exp Hematol"},{"key":"763_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01321893","volume":"53","author":"J Monkkonen","year":"1993","unstructured":"Monkkonen J, Heath TD (1993) The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: the role of calcium and iron. Calcif Tissue Int 53:139\u2013146","journal-title":"Calcif Tissue Int"},{"key":"763_CR23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/10611869409015910","volume":"2","author":"J Monkkonen","year":"1994","unstructured":"Monkkonen J, Taskinen M, Auriola SO, Urtti A (1994) Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. J Drug Target 2:299\u2013308","journal-title":"J Drug Target"},{"key":"763_CR24","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.4049\/jimmunol.152.6.2930","volume":"152","author":"KJ Moore","year":"1994","unstructured":"Moore KJ, Matlashewski G (1994) Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol 152:2930\u20132937","journal-title":"J Immunol"},{"key":"763_CR25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1354\/vp.43-5-632","volume":"43","author":"PF Moore","year":"2006","unstructured":"Moore PF, Affolter VK, Vernau W (2006) Canine hemophagocytic histiocytic sarcoma: a proliferative disorder of CD11d+ macrophages. Vet Pathol 43:632\u2013645","journal-title":"Vet Pathol"},{"key":"763_CR26","doi-asserted-by":"crossref","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","volume":"12","author":"AJ Roelofs","year":"2006","unstructured":"Roelofs AJ, Thompson K, Gordon S, Rogers MJ (2006) Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 12:6222s\u20136230s","journal-title":"Clin Cancer Res"},{"key":"763_CR27","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","volume":"88","author":"MJ Rogers","year":"2000","unstructured":"Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88:2961\u20132978","journal-title":"Cancer"},{"key":"763_CR28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF00299317","volume":"55","author":"K Selander","year":"1994","unstructured":"Selander K, Lehenkari P, Vaananen HK (1994) The effects of bisphosphonates on the resorption cycle of isolated osteoclasts. Calcif Tissue Int 55:368\u2013375","journal-title":"Calcif Tissue Int"},{"key":"763_CR29","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0026-895X(25)09541-0","volume":"50","author":"KS Selander","year":"1996","unstructured":"Selander KS, Monkkonen J, Karhukorpi EK, Harkonen P, Hannuniemi R, Vaananen HK (1996) Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. Mol Pharmacol 50:1127\u20131138","journal-title":"Mol Pharmacol"},{"key":"763_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semcancer.2005.07.005","volume":"16","author":"P Serafini","year":"2006","unstructured":"Serafini P, Borrello I, Bronte V (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 16:53\u201365","journal-title":"Semin Cancer Biol"},{"key":"763_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1939-1676.2007.tb02937.x","volume":"21","author":"KA Skorupski","year":"2007","unstructured":"Skorupski KA, Clifford CA, Paoloni MC, Lara-Garcia A, Barber L, Kent MS, LeBlanc AK, Sabhlok A, Mauldin EA, Shofer FS, Couto CG, Sorenmo KU (2007) CCNU for the treatment of dogs with histiocytic sarcoma. J Vet Int Med 21:121\u2013126","journal-title":"J Vet Int Med"},{"key":"763_CR32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/bjc.1987.190","volume":"56","author":"PR Twentyman","year":"1987","unstructured":"Twentyman PR, Luscombe M (1987) A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56:279\u2013285","journal-title":"Br J Cancer"},{"key":"763_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R","volume":"31","author":"M Engeland van","year":"1998","unstructured":"van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1\u20139","journal-title":"Cytometry"},{"key":"763_CR34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02556058","volume":"45","author":"N Rooijen van","year":"1989","unstructured":"van Rooijen N, Kors N (1989) Effects of intracellular diphosphonates on cells of the mononuclear phagocyte system: in vivo effects of liposome-encapsulated diphosphonates on different macrophage subpopulations in the spleen. Calcif Tissue Int 45:153\u2013156","journal-title":"Calcif Tissue Int"},{"key":"763_CR35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02899217","volume":"54","author":"N Rooijen van","year":"1988","unstructured":"van Rooijen N, Kors N, ter Hart H, Claassen E (1988) In vitro and in vivo elimination of macrophage tumor cells using liposome-encapsulated dichloromethylene diphosphonate. Virchows Arch B Cell Pathol Incl Mol Pathol 54:241\u2013245","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"763_CR36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","volume":"174","author":"N Rooijen Van","year":"1994","unstructured":"Van Rooijen N, Sanders A (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174:83\u201393","journal-title":"J Immunol Methods"},{"key":"763_CR37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0022-1759(96)00056-7","volume":"193","author":"N Rooijen van","year":"1996","unstructured":"van Rooijen N, Sanders A, van den Berg TK (1996) Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J Immunol Methods 193:93\u201399","journal-title":"J Immunol Methods"},{"key":"763_CR38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","volume":"184","author":"I Vermes","year":"1995","unstructured":"Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184:39\u201351","journal-title":"J Immunol Methods"},{"key":"763_CR39","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S8756-3282(02)00841-4","volume":"31","author":"K Villikka","year":"2002","unstructured":"Villikka K, Perttunen K, Rosnell J, Ikavalko H, Vaho H, Pylkkanen L (2002) The absolute bioavailability of clodronate from two different oral doses. Bone 31:418\u2013421","journal-title":"Bone"},{"key":"763_CR40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02623551","volume":"24","author":"ML Wellman","year":"1988","unstructured":"Wellman ML, Krakowka S, Jacobs RM, Kociba GJ (1988) A macrophage-monocyte cell line from a dog with malignant histiocytosis. In Vitro Cell Dev Biol 24:223\u2013229","journal-title":"In Vitro Cell Dev Biol"},{"key":"763_CR41","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1200\/JCO.1996.14.7.2073","volume":"14","author":"B Willis","year":"1996","unstructured":"Willis B, Ablin A, Weinberg V, Zoger S, Wara WM, Matthay KK (1996) Disease course and late sequelae of Langerhans\u2019 cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol 14:2073\u20132082","journal-title":"J Clin Oncol"},{"key":"763_CR42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2460\/ajvr.67.4.633","volume":"67","author":"R Zavodovskaya","year":"2006","unstructured":"Zavodovskaya R, Liao AT, Jones CL, Yip B, Chien MB, Moore PF, London CA (2006) Evaluation of dysregulation of the receptor tyrosine kinases Kit, Flt3, and Met in histiocytic sarcomas of dogs. Am J Vet Res 67:633\u2013641","journal-title":"Am J Vet Res"},{"key":"763_CR43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.bjc.6603240","volume":"95","author":"SM Zeisberger","year":"2006","unstructured":"Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer K, Schwendener RA (2006) Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95:272\u2013281","journal-title":"Br J Cancer"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-009-0763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-009-0763-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-009-0763-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T04:51:33Z","timestamp":1739335893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-009-0763-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,16]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1007\/s00262-009-0763-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,16]]}}}